For type 2 diabetes, your options include: DPP-4 inhibitors GLP-1 receptor agonists (Ozempic, Trulicity, Victoza) GLP-1/GIP receptor agonists (Mounjaro) SGLT2 inhibitors Thiazolidinediones And prescription weight-loss medications that are currently available include: Orforglipron, an oral small-molecule non-peptide GLP-1 receptor agonist ( Foundayo ) GLP-1/GIP receptor agonists ( Zepbound ) Phentermine-topiramate ( Qsymia ) Bupropion-naltrexone ( Contrave ) Your clinician, like those through Weight Watchers Med+ , can go over your available options and, if you qualify, prescribe medication and a lifestyle plan designed for your body and your goals.* Retatrutide warnings and precautions Despite the fact that retatrutide is not an approved medication, there is active marketing for medications being characterized as retatrutide. Because retatrutide is still investigational, there is no regulated manufacturing or supply chain, meaning you cannot be sure what you are actually receiving and putting in your body, says Rhodes

These medication pathways make it increasingly difficult for employers to maintain visibility into GLP-1 use and related risk, progress, or safety for their employees
Therefore gallstone rates increase
Let us help you optimize your health from the inside out with a personalized NAD IV Therapy treatment plan.
Ligand-activated RXFP1 gene therapy ameliorates pressure overload-induced cardiac dysfunction
Maintenance dosing at 0.160.25mg twice weekly sustains approximately 7085% of peak melanogenesis indefinitely without requiring continuous daily administration